EBR Systems (EBRCZ) FCF Margin (2025 - 2026)
EBR Systems' (EBRCZ) quarterly FCF Margin came in at 996.66% in Q1 2026, up 43.4% quarter-over-quarter from 1760.83% in Q4 2025.
EBR Systems (EBRCZ) FCF Margin (2025 - 2026) Analysis & Trends
EBR Systems has disclosed FCF Margin across 2 years of filings, most recently posting 996.66% for Q1 2026.
- FCF Margin for Q1 2026 came in at 996.66%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 1678.61% (changed N/A YoY), and the FY2025 annual result was 3517.32%, changed N/A from the prior year.
- FCF Margin came in at 996.66% for Q1 2026 at EBR Systems, up from 1760.83% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 996.66% in Q1 2026 to a low of 7286.23% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.44% |
| 10 | EBR Systems | - | - | 184,000.00 | -996.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -996.66% |
| Dec 31, 2025 | -1,760.83% |
| Sep 30, 2025 | -2,815.62% |
| Jun 30, 2025 | -7,286.23% |